Article History
Received: 25 July 2022
Revised: 1 March 2023
Accepted: 2 March 2023
First Online: 29 March 2023
Declarations
:
: For full disclosure, we provide here an additional list of other author commitments and funding sources that are not directly related to this study: David J Askenazi is a consultant for Baxter, Nuwellis, Medtronic Bioporto, and Seastar. His institution receives grant funding for education and research that is not related to this project from NIH, Baxter, Nuwellis, Medtronic, Bioporto, and Seastar. He has patents pending on inventions to improve the kidney care of neonates. He is the Founder and Chief Scientific Officer for Zorro-Flow Inc. Kyle Deville is on the T32 DK007545 NIH-NRSA funded training grant 'Interdisciplinary Training in Kidney-Related Research'.